Mapi Pharma receives US patent for multiple sclerosis treatm

A board to discuss the Multiple Sclerosis modifying drug Copaxone

Mapi Pharma receives US patent for multiple sclerosis treatm

Postby MSUK » Thu May 09, 2013 1:14 am

Mapi Pharma, developer of complex bulk Active Pharmaceutical Ingredients (APIs), has been granted a US patent for a long acting depot formulation of glatiramer acetate, which is under the development as a once-a-month treatment for Multiple Sclerosis (MS).... Read More - http://www.ms-uk.org/index.cfm/copaxone
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2180
Joined: Wed Oct 14, 2009 3:00 pm

Advertisement

Return to Copaxone

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service